Abstract
Early pharmacological prophylaxis has been reported to increase the return of spontaneous erections following radical prostatectomy (RP). In this study, we evaluated the role of intracavernosal alprostadil (PGE1) combined with sildenafil in stimulating early recovery of spontaneous erections following RP. In this prospective study, we included 22 patients who underwent bilateral nerve-sparing RP after October 2004. Sildenafil dose of 50 mg/day was started at the time of hospital discharge. Of 22 patients, 18 started on PGE1–4 μg (1–8) and four started on low-dose Trimix (20 U) 2–3 times/week. These patients are followed up at regular intervals (3, 6, 9 and 12 months) with abridged version of the International Index for Erectile Function-5 questionnaire. Patient compliance, return of sexual activity and return of natural erection, adverse effects and reasons for discontinuation were recorded. Penile doppler studies were performed during followup visits to assess the vascular status. After a mean followup of 6 months (3–8 months), 11/22 (50%) patients had return of spontaneous partial erections. Of the 18 PGE1 users, six continued 4 μg PGE1, four increased the dose to 8 μg, six decreased the dose to 2 μg and two patients further reduced the dose to 1 μg. Of four low-dose Trimix users, three increased the dose to 30 U and one reduced the dose to 15 U. Of 22 patients, 21 were sexually active: 12/21 (57%) with the injections alone and 9/21 (42.9%) with combination therapy (injections (PGE1) and sildenafil). Penile doppler studies revealed arterial insufficiency in 77% (17/22) patients and venous insufficiency in one patient. Early intracavernosal injections following RP facilitated early sexual intercourse, patient satisfaction and potentially earlier return of natural erections. Early combination therapy with sildenafil allowed a lower dose of intracavernous injections, minimizing the penile discomfort.
Similar content being viewed by others
References
Zippe CD, Raina R, Thukral M, Lakin MM, Klein EA, Agarwal A . Management of erectile dysfunction following radical prostatectomy. Curr Urol Rep 2001; 2: 495–503.
Catalona WJ, Basler JW . Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993; 150: 905–907.
Walsh PC, Marschke P, Ricker D, Burnett AL . Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55: 58–61.
McCullough AR . Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 2001; 28: 613–627.
Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V . Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173: 1673–1676.
Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167: 1371–1375.
Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408–1410.
Schwartz EJ, Wong P, Graydon RJ . Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171: 771–774.
Padma-Nathan H, McCullough AR, Giuliano F, Toler SM, Wohlhuter LF, Nava L et al. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol (Suppl) 2003; 169: 375, (abstract, 1402).
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.
Patel U, Lees WR . Penile sonography. In: Solbiati L, Rizzato G (eds). Ultrasound of Superficial Structures. Churchill-Livingstone: London, 1995, pp 229–242.
Raina R, Agarwal A, Goyal KK, Jackson C, Ulchaker J, Angermeier K et al. Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate. Urology 2003; 62: 1103–1108.
Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT . Factors predicting recovery of erections after radical prostatectomy. J Urol 2000; 164: 1929–1934.
Fraiman MC, Lepor H, McCullough AR . Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy. Mol Urol 1999; 3: 109–115.
Linet OI, Ogrinc FG . Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 1996; 334: 873–877.
Mulhall JP, Graydon RJ . The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res 1996; 8: 91–94.
Moreland RB, Traish A, McMillin MA, Smith B, Goldstein I, Saenz de Tejada I . PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995; 153: 826–834.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nandipati, K., Raina, R., Agarwal, A. et al. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections. Int J Impot Res 18, 446–451 (2006). https://doi.org/10.1038/sj.ijir.3901448
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901448
- Springer Nature Limited
Keywords
This article is cited by
-
Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study
International Journal of Impotence Research (2022)
-
Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil
International Journal of Impotence Research (2018)
-
Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails
Drugs & Aging (2018)
-
What is the current role of intracavernosal injection in management of erectile dysfunction?
International Journal of Impotence Research (2016)
-
A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients
International Journal of Impotence Research (2015)